Loading...
Create a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsCreate a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsCPT 87260: Adenovirus Antigen Detection by Immunofluorescence
CPT-87265-BORDETELLA-IMMUNOFLUORESCENT-ANTIGEN-DETECTIONCPT 87265: Immunofluorescent Antigen Detection for Bordetella
CPT-87267-ENTEROVIRUS-DFA-ANTIGEN-DETECTIONCPT 87267: Enterovirus Antigen Detection by Direct Fluorescent Antibody
CPT-87269-GIARDIA-IMMUNOFLUORESCENT-ANTIGEN-DETECTIONCPT 87269: Immunofluorescent Detection of Giardia Antigen
CPT-87270-CHLAMYDIA-TRACHOMATIS-IMMUNOFLUORESCENT-ANTIGEN-DETECTIONCPT 87270: Chlamydia trachomatis Antigen Detection by Immunofluorescence
CPT-87271-CMV-DFA-ANTIGEN-DETECTIONCPT 87271: Cytomegalovirus Antigen Detection by DFA
CPT-87272-CRYPTOSPORIDIUM-IMMUNOFLUORESCENT-ANTIGEN-DETECTIONCPT 87272: Cryptosporidium Antigen Immunofluorescent Test
CPT-87273-HSV-2-ANTIGEN-IMMUNOFLUORESCENCECPT 87273: HSV-2 Antigen Detection by Immunofluorescence
CPT-87274-HSV-1-ANTIGEN-IMMUNOFLUORESCENCECPT 87274: HSV-1 Antigen Detection by Immunofluorescence
CPT-87275-INFLUENZA-B-IMMUNOFLUORESCENT-ANTIGEN-DETECTIONCPT 87275: Influenza B Antigen Detection by Immunofluorescence
Showing 1–10 of 168
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.